Side Effects: Why Dose Strategy Matters GLP-1 medications can cause gastrointestinal side effects, especially during the first few weeks of treatment or after a dose increase
did not observe significant differences in amputation risk between GLP-1 receptor agonists, SGLT-2 inhibitors, and other diabetes medications in a large retrospective cohort study of 1,222,436 patients with type 2 diabetes
doi: 10.1007/s40262-021-01025-x
We overcome this by triangulating our conclusions and recommendations based on the findings from multiple studies and the consistent oral vitamin B12 dosage of 1000 g
Furthermore, combination therapy trials exploring the synergistic effects of GLP-1RAs with biologics could uncover new approaches for treatment, enhancing the management both metabolic and immunologic aspects in PsA
Human growth hormone (somatropin) for the treatment of growth failure in children (TA188)